Company Profile

Cell Signaling Technology Inc
Profile last edited on: 10/10/21      CAGE: 3LTH3      UEI: DEUMJK7A3NH4

Business Identifier: proteomics-focused
Year Founded
1999
First Award
2002
Latest Award
2009
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3 Trask Lane
Danvers, MA 01923
   (978) 867-2300
   info@cellsignal.com
   www.cellsignal.com
Location: Multiple
Congr. District: 06
County: Essex

Public Profile

Cell Signaling Technology, Inc. (CST) develops innovative research tools such as these to help define the mechanisms underlying cell function and disease, thereby broadly accelerating progress in biomedical research and medicine. Aberrant signaling within these pathways has been implicated in various diseases including cancer, diabetes and neurodegenerative diseases.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
150-249
Revenue Range
15M-20M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
50-74

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2009 2 NIH $1,303,524
Project Title: PhosphoSite. and the Phosphoproteome of Cancer
2007 1 NIH $151,911
Project Title: Finding Acetylated-Lysine Sites in the Cancer Proteome
2007 2 NIH $1,982,776
Project Title: Immunoaffinity Isolation of Phosphopeptides
2004 2 NIH $1,306,440
Project Title: Development of a Protein Phosphorylation Site Database

Key People / Management

  Michael Comb -- President

  Peter V Hornbeck -- Senior Scientist

  John Rush -- Director of Protein Chemistry

Company News

There are no news available.